Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-23-013004

President and CEO sold 27,750 shares at an average $24.53 ($680,747)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SCANGOS GEORGE A President and CEO 2023-02-23 Sale −12,631 $25.97 $328,065 183,608 D: show line 1 in the form
SCANGOS GEORGE A President and CEO 2023-02-24 Sale −4,239 $22.74 $96,382 179,369 D: show line 2 in the form
SCANGOS GEORGE A President and CEO 2023-02-24 Sale −10,880 $23.56 $256,300 168,489 D: show line 3 in the form
Open-market sales · 27,750 sh · avg $24.53 · $680,747
Loading xslF345X03/doc4.xml…